• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[顺铂辅助局部化疗用于浅表性膀胱癌]

[Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer].

作者信息

Flamm J, Grof F

出版信息

Urologe A. 1986 Jan;25(1):48-50.

PMID:3962044
Abstract

During a period of 6 weeks we applied a weekly dosage of 50 mg of cis-platinum as an intravesical instillation treatment to 30 patients with superficial carcinomas of the urinary bladder. Prior to this treatment these patients had undergone a transurethral differentiated resection of their tumours by multiple biopsies (mapping). Persistent tumours were found in 3 patients (10%). After an observation time of 22 months the relapse rate in pTa tumours was 5.5 and in pT1 tumours 7.6.

摘要

在6周的时间里,我们对30例膀胱浅表癌患者进行了每周一次、每次50毫克顺铂的膀胱内灌注治疗。在该治疗之前,这些患者已通过多次活检(定位)接受了经尿道肿瘤分化切除术。3例患者(10%)发现有持续性肿瘤。经过22个月的观察期,pTa期肿瘤的复发率为5.5%,pT1期肿瘤的复发率为7.6%。

相似文献

1
[Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer].[顺铂辅助局部化疗用于浅表性膀胱癌]
Urologe A. 1986 Jan;25(1):48-50.
2
Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.经尿道膀胱肿瘤电切术后早期膀胱内灌注化疗的可行性:对连续210例患者的前瞻性评估
Scand J Urol Nephrol. 2008;42(6):522-7. doi: 10.1080/00365590802133099.
3
Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.采用标准化槲寄生提取物进行膀胱内辅助治疗以预防浅表性膀胱癌复发。
Anticancer Res. 2005 Nov-Dec;25(6C):4733-6.
4
[Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin].
Urologe A. 1985 Jan;24(1):31-5.
5
Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.用槲寄生凝集素预防浅表性膀胱癌复发的非常规治疗方式评估:一项随机II期试验。
J Urol. 2002 Jul;168(1):72-5.
6
[Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].[卡介苗辅助膀胱内灌注治疗3级浅表性膀胱癌的结果]
Hinyokika Kiyo. 2004 Nov;50(11):767-71.
7
The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.p53和bcl-2在浅表性膀胱移行细胞癌中的表达及其在术后膀胱内化疗结局中的作用。
Anticancer Res. 1998 Nov-Dec;18(6B):4717-21.
8
Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.pTa/pT1期膀胱癌患者局部复发的危险因素。
Scand J Urol Nephrol. 2008;42(5):417-21. doi: 10.1080/00365590802016302.
9
Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.用标准化槲寄生提取物对浅表性膀胱癌进行膀胱内辅助治疗。
J Urol. 2005 Jul;174(1):76-9. doi: 10.1097/01.ju.0000163261.08619.d0.
10
Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.膀胱内注射表柔比星与多柔比星治疗浅表性膀胱肿瘤(pTa和pT1期):一项随机前瞻性研究。
J Urol. 1997 Jul;158(1):68-73; discussion 73-4. doi: 10.1097/00005392-199707000-00018.